Risks of Men Taking Female Hormones
Though rarely used in men, female hormones such as estrogen and progesterone can be taken by males for medical conditions such as testicular cancer, prostate enlargement and aromatase deficiency 3. Female hormone treatment in men carries a number of risks, because it suppresses the production of testosterone 1.
Sexual Changes
Because testosterone is responsible for the development and maintenance of the male sex characteristics, when testosterone levels are opposed by higher levels of female hormones, testosterone will become less effective. Men who take female hormones may be subject to a number of changes affecting the physical state and functioning of the sex organs. These risks may include decreased testes size, lowered sperm count and erectile dysfunction along with loss of libido. In addition, men taking female hormones may develop gynecomastia, or the growth of breast tissue in men, along with darkening and enlargement of the nipples.
- Because testosterone is responsible for the development and maintenance of the male sex characteristics, when testosterone levels are opposed by higher levels of female hormones, testosterone will become less effective.
- In addition, men taking female hormones may develop gynecomastia, or the growth of breast tissue in men, along with darkening and enlargement of the nipples.
Physical Changes
Side Effects of Men Taking Female Birth Control Pills
Learn More
Testosterone is primarily responsible for the development of muscle mass and bone tissue in men. With female hormone usage, large muscle groups such as the chest, legs and arms may begin to shrink and bones may become more porous and brittle, thereby contributing to weakness and bone fracture. In addition, fat storage in men who take hormones may be increased, leading to a feminization of body shape. Facial and body hair may begin to grow more slowly; however male pattern baldness may improve as it is primarily caused by a metabolite of testosterone.
- Testosterone is primarily responsible for the development of muscle mass and bone tissue in men.
- Facial and body hair may begin to grow more slowly; however male pattern baldness may improve as it is primarily caused by a metabolite of testosterone.
Mental Changes
As testosterone is a male hormone, thought to play a factor in assertiveness and aggression, men who take female hormones may become less assertive. Some men may lose interest in previously pleasurable activities, including sex. These changes may reverse themselves once the female hormones are discontinued, but some men may develop depression from both the use of hormones and from self esteem issues that may arise from physical changes. Some men may experience hot flashes, similar to those seen during menopause as well as other problems such as insomnia and forgetfulness.
- As testosterone is a male hormone, thought to play a factor in assertiveness and aggression, men who take female hormones may become less assertive.
- Some men may experience hot flashes, similar to those seen during menopause as well as other problems such as insomnia and forgetfulness.
Increased Disease Risk
Emotional Side Effects of Steroids
Learn More
As breast tissue is developed, there may be a corresponding increase in the risk of breast cancer. There is also an increased risk of stroke due to the development of clots related to female hormone usage, particularly among smokers, but a decreased chance of heart attack is probable. An increased chance of the development of liver and gall bladder disease may be seen; however a decreased risk in the development and growth of prostate enlargement and prostate cancer is possible.
- As breast tissue is developed, there may be a corresponding increase in the risk of breast cancer.
- An increased chance of the development of liver and gall bladder disease may be seen; however a decreased risk in the development and growth of prostate enlargement and prostate cancer is possible.
Related Articles
References
- Drugs.com: Estradiol Side Effects
- Drugs.com: Progesterone Side Effects
- Nassar GN, Leslie SW. Physiology, Testosterone. [Updated 2018 Oct 27]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2019 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK526128/
- Sizar O, Schwartz J. Hypogonadism. [Updated 2019 Jun 4]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2019 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK532933/
- Stanworth RD, Jones TH. Testosterone for the aging male; current evidence and recommended practice. Clin Interv Aging. 2008;3(1):25–44. doi:10.2147/cia.s190
- McBride JA, Carson CC 3rd, Coward RM. Testosterone deficiency in the aging male. Ther Adv Urol. 2016;8(1):47–60. doi:10.1177/1756287215612961
- Kumar P, Kumar N, Thakur DS, Patidar A. Male hypogonadism: Symptoms and treatment. J Adv Pharm Technol Res. 2010;1(3):297–301. doi:10.4103/0110-5558.72420
- Johnson JM, Nachtigall LB, Stern TA. The effect of testosterone levels on mood in men: a review. Psychosomatics. 2013;54(6):509-14.
- Rajfer J. Relationship between testosterone and erectile dysfunction. Rev Urol. 2000;2(2):122–128.
- Barrett-Connor E, Dam TT, Stone K, et al. The association of testosterone levels with overall sleep quality, sleep architecture, and sleep-disordered breathing. J Clin Endocrinol Metab. 2008;93(7):2602–2609. doi:10.1210/jc.2007-2622
- Beauchet O. Testosterone and cognitive function: current clinical evidence of a relationship. Eur J Endocrinol. 2006;155(6):773-81.
- Golds G, Houdek D, Arnason T. Male Hypogonadism and Osteoporosis: The Effects, Clinical Consequences, and Treatment of Testosterone Deficiency in Bone Health. Int J Endocrinol. 2017;2017:4602129. doi:10.1155/2017/4602129
- Grossmann M, Thomas MC, Panagiotopoulos S, et al. Low testosterone levels are common and associated with insulin resistance in men with diabetes. J Clin Endocrinol Metab. 2008;93(5):1834-40.
- Cai Z, Xi H, Pan Y, et al. Effect of testosterone deficiency on cholesterol metabolism in pigs fed a high-fat and high-cholesterol diet. Lipids Health Dis. 2015;14:18. Published 2015 Mar 7. doi:10.1186/s12944-015-0014-5
- Ferrucci L, Maggio M, Bandinelli S, et al. Low testosterone levels and the risk of anemia in older men and women. Arch Intern Med. 2006;166(13):1380–1388. doi:10.1001/archinte.166.13.1380
- Nassar GN, Leslie SW. Physiology, Testosterone. [Updated 2018 Oct 27]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2019 Jan-.
- Rivas AM, Mulkey Z, Lado-Abeal J, Yarbrough S. Diagnosing and managing low serum testosterone. Proc (Bayl Univ Med Cent). 2014;27(4):321–324. doi:10.1080/08998280.2014.11929145
- Kanakis GA, Nieschlag E. Klinefelter syndrome: more than hypogonadism. Metab Clin Exp. 2018;86:135-144.
- Sizar O, Schwartz J. Hypogonadism. [Updated 2019 Jun 4]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2019 Jan-.
- Nahata L, Yu RN, Bhasin S, Cohen LE. Management of testosterone therapy in adolescents and young men with hypogonadism: are we following adult clinical practice guidelines?. J Pediatr Endocrinol Metab. 2015;28(5-6):635-40.
- McBride JA, Carson CC, Coward RM. Diagnosis and management of testosterone deficiency. Asian J Androl. 2015;17(2):177–186. doi:10.4103/1008-682X.143317
- Crawford ED, Poage W, Nyhuis A, et al. Measurement of testosterone: how important is a morning blood draw?. Curr Med Res Opin. 2015;31(10):1911-4.
- Wersinger SR, Haisenleder DJ, Lubahn DB, Rissman EF. Steroid feedback on gonadotropin release and pituitary gonadotropin subunit mRNA in mice lacking a functional estrogen receptor alpha. Endocrine. 1999;11(2):137-43.
- Rhoden EL, Estrada C, Levine L, Morgentaler A. The value of pituitary magnetic resonance imaging in men with hypogonadism. J Urol. 2003;170(3):795-8.
- Snyder PJ, Kopperdahl DL, Stephens-Shields AJ, et al. Effect of Testosterone Treatment on Volumetric Bone Density and Strength in Older Men With Low Testosterone: A Controlled Clinical Trial [published correction appears in JAMA Intern Med. 2017 Apr 1;177(4):600] [published correction appears in JAMA Intern Med. 2019 Mar 1;179(3):457]. JAMA Intern Med. 2017;177(4):471–479. doi:10.1001/jamainternmed.2016.9539
- Huo S, Scialli AR, McGarvey S, et al. Treatment of Men for "Low Testosterone": A Systematic Review. PLoS One. 2016;11(9):e0162480. Published 2016 Sep 21. doi:10.1371/journal.pone.0162480
- Armamento-Villareal R, Aguirre LE, Qualls C, Villareal DT. Effect of Lifestyle Intervention on the Hormonal Profile of Frail, Obese Older Men. J Nutr Health Aging. 2016;20(3):334–340. doi:10.1007/s12603-016-0698-x
- American Urological Association. Evaluation and management of testosterone deficiency.
- Grech A, Breck J, Heidelbaugh J. Adverse effects of testosterone replacement therapy: an update on the evidence and controversy. Ther Adv Drug Saf. 2014;5(5):190–200. doi:10.1177/2042098614548680
- American Urological Association, Evaluation and Management of Testosterone Deficiency.
- Fillo J, Breza J Jr, Ondrusova M, Luha J, Ondrus D, Dubravicky J, et al. Results of long term testosterone replacement therapy in men with abdominal obesity, erectile dysfunction and testosterone deficiency. Bratisl Lek Listy. 2018;119(9):577-580. doi:10.4149/BLL_2018_061
- Tremellen K, McPhee N, Pearce K, Benson S, Schedlowski M, Engler H. Endotoxin-initiated inflammation reduces testosterone production in men of reproductive age. Am J Physiol Endocrinol Metab. 2018 Mar 1;314(3):E206-E213. doi:10.1152/ajpendo.00279.2017. Epub 2017 Nov 28.
Writer Bio
Melissa Lind holds a Bachelor of Science degree from the University of Texas College of Pharmacy. She has over 20 years experience as a health-care professional, including pharmacy practice as a registered pharmacist, and experience in clinical research management and community college instruction in pharmacology and health topics. Lind has been a freelance writer and independent content provider since 2006.